<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating 
autophagy signaling pathway in hepatic stellate cells.

Ferroptosis is a recently discovered form of programmed cell death, but its 
regulatory mechanisms remain poorly understood. Here, we show that the 
RNA-binding protein ZFP36/TTP (ZFP36 ring finger protein) plays a crucial role 
in regulating ferroptosis in hepatic stellate cells (HSCs). Upon exposure to 
ferroptosis-inducing compounds, the ubiquitin ligase FBXW7/CDC4 (F-box and WD 
repeat domain containing 7) decreased ZFP36 protein expression by recognizing 
SFSGLPS motif. FBXW7 plasmid contributed to classical ferroptotic events, 
whereas ZFP36 plasmid impaired FBXW7 plasmid-induced HSC ferroptosis. 
Interestingly, ZFP36 plasmid inhibited macroautophagy/autophagy activation by 
destabilizing ATG16L1 (autophagy related 16 like 1) mRNA. ATG16L1 plasmid 
eliminated the inhibitory action of ZFP36 plasmid on ferroptosis, and FBXW7 
plasmid enhanced the effect of ATG16L1 plasmid on autophagy. Importantly, ZFP36 
plasmid promoted ATG16L1 mRNA decay via binding to the AU-rich elements (AREs) 
within the 3'-untranslated region. The internal mutation of the ARE region 
abrogated the ZFP36-mediated ATG16L1 mRNA instability, and prevented ZFP36 
plasmid-mediated ferroptosis resistance. In mice, treatment with erastin and 
sorafenib alleviated murine liver fibrosis by inducing HSC ferroptosis. 
HSC-specific overexpression of Zfp36 impaired erastin- or sorafenib-induced HSC 
ferroptosis. Noteworthy, we analyzed the effect of sorafenib on HSC ferroptosis 
in fibrotic patients with hepatocellular carcinoma receiving sorafenib 
monotherapy. Attractively, sorafenib monotherapy led to ZFP36 downregulation, 
ferritinophagy activation, and ferroptosis induction in human HSCs. Overall, 
these results revealed novel molecular mechanisms and signaling pathways of 
ferroptosis, and also identified ZFP36-autophagy-dependent ferroptosis as a 
potential target for the treatment of liver fibrosis.]]></TEXT>
<TAGS>
<PERTURBING_ACTION id="P0" spans="610~623" text="FBXW7 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P1" spans="678~691" text="ZFP36 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P2" spans="701~714" text="FBXW7 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P3" spans="756~769" text="ZFP36 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P4" spans="878~893" text="ATG16L1 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P5" spans="931~944" text="ZFP36 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P6" spans="965~979" text="FBXW7  plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P7" spans="1003~1018" text="ATG16L1 plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P8" spans="1046~1060" text="ZFP36  plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P9" spans="1278~1292" text="ZFP36  plasmid" perturbingaction="gene gain-of-function" />
<PERTURBING_ACTION id="P10" spans="1436~1472" text="HSC-specific overexpression of Zfp36" perturbingaction="gene gain-of-function" />
<CONTEXT id="C0" spans="723~726" text="HSC" context="cells" />
<CONTEXT id="C1" spans="1329~1333" text="mice" context="organism" />
<CONTEXT id="C2" spans="1384~1396" text="murine liver" context="tissue/organ" />
<CONTEXT id="C3" spans="1418~1421" text="HSC" context="cells" />
<CONTEXT id="C4" spans="1512~1515" text="HSC" context="cells" />
<CONTEXT id="C5" spans="1805~1815" text="human HSCs" context="cells" />
<PHENOTYPE id="PH0" spans="649~667" text="ferroptotic events" phenotype="ferroptosis" />
<PHENOTYPE id="PH1" spans="727~738" text="ferroptosis" phenotype="ferroptosis" />
<PHENOTYPE id="PH2" spans="795~804" text="autophagy" phenotype="autophagy" />
<PHENOTYPE id="PH3" spans="948~959" text="ferroptosis" phenotype="ferroptosis" />
<PHENOTYPE id="PH4" spans="1022~1031" text="autophagy" phenotype="autophagy" />
<PHENOTYPE id="PH5" spans="1302~1313" text="ferroptosis" phenotype="ferroptosis" />
<PHENOTYPE id="PH6" spans="1422~1433" text="ferroptosis" phenotype="ferroptosis" />
<PHENOTYPE id="PH7" spans="1517~1528" text="ferroptosis" phenotype="ferroptosis" />
<PHENOTYPE id="PH8" spans="1780~1791" text="ferroptosis" phenotype="ferroptosis" />
<EFFECT id="E0" spans="624~638" text="contributed to" effect="positive" />
<EFFECT id="E1" spans="692~700" text="impaired" effect="negative" />
<EFFECT id="E2" spans="715~722" text="induced" effect="positive" />
<EFFECT id="E3" spans="770~779" text="inhibited" effect="negative" />
<EFFECT id="E4" spans="910~927" text="inhibitory action" effect="negative" />
<EFFECT id="E5" spans="1314~1324" text="resistance" effect="negative" />
<EFFECT id="E6" spans="1409~1417" text="inducing" effect="positive" />
<EFFECT id="E7" spans="1473~1481" text="impaired" effect="negative" />
<EFFECT id="E8" spans="1792~1801" text="induction" effect="positive" />
<ENTITY_LINKING id="EN0" perturbing_actionID="P1" perturbing_actionText="ZFP36 plasmid" effectID="E1" effectText="impaired" contextID="C0" contextText="HSC" phenotypeID="PH1" phenotypeText="ferroptosis" />
<ENTITY_LINKING id="EN1" perturbing_actionID="P2" perturbing_actionText="FBXW7 plasmid" contextID="C0" contextText="HSC" effectID="E2" effectText="induced" phenotypeID="PH1" phenotypeText="ferroptosis" />
<ENTITY_LINKING id="EN2" perturbing_actionID="P10" perturbing_actionText="HSC-specific overexpression of Zfp36" effectID="E7" effectText="impaired" contextID="C4" contextText="HSC" phenotypeID="PH7" phenotypeText="ferroptosis" />
</TAGS>
</Genomics_ConceptTask>